Blood-based biomarker tests (screening) for colorectal cancer
Medicare Coverage Information
Overview
Medicare provides coverage for certain blood-based biomarker tests as a screening method for colorectal cancer. These advanced tests offer a non-invasive option for early cancer detection, helping beneficiaries monitor their health proactively.
- Covers blood-based biomarker tests for colorectal cancer screening
- Designed as a preventive health service
- May reduce need for more invasive screening procedures
- Typically covered for eligible Medicare beneficiaries
- Medicare Part B beneficiaries
- Typically for individuals at average or increased risk of colorectal cancer
- Age and medical history may impact coverage
- Likely covered at 100% with no out-of-pocket costs as a preventive service
- Potential copayment or coinsurance may apply depending on specific Medicare plan
- Must be ordered by a qualified healthcare provider
- Coverage may depend on specific medical guidelines and risk factors
- Not all blood-based tests may be covered
- Consult with your healthcare provider about blood-based biomarker screening
- Verify specific coverage details with your Medicare plan
- Call 1-800-MEDICARE for precise coverage information
Last updated: 6/15/2025
Quick Information
- Provider
- Medicare
- Last Updated
- 6/15/2025
- Topics
- Medicarecolorectal cancer screeningblood-based biomarker testcancer detectionpreventive screening
Related Coverage Topics
Questions About Blood-based biomarker tests (screening) for colorectal cancer?
Our experts can help you understand your Medicare coverage for blood-based biomarker tests (screening) for colorectal cancer. Get personalized guidance on costs, eligibility, and next steps.